|
WO2021058809A1
|
|
A novel complex formed between the flaviviral non-structural ns1 protein and plasma lipoproteins
|
|
US10948490B1
|
|
Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics
|
|
WO2020245663A1
|
|
Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection
|
|
WO2020229629A1
|
|
Multiplexable microfluidic culture chamber for imaging monolayer growth of single cells
|
|
WO2020229893A1
|
|
Live imaging system to visualize the retro-transcribed viral dna genome
|
|
WO2020194063A1
|
|
A live and attenuated flavivirus comprising a mutated m protein
|
|
WO2020148458A1
|
|
Aav-mediated gene therapy restoring the otoferlin gene
|
|
WO2020128033A1
|
|
Cellular metabolism of hiv-1 reservoir seeding in cd4+ t cells
|
|
WO2020104382A1
|
|
Combination of pejvakin and lc3b for treating hearing losses
|
|
WO2020008066A1
|
|
Human immune system mouse model
|
|
WO2019224607A1
|
|
Recombinant measles virus expressing proteins of a plasmodium parasite and their applications
|
|
EP3796931A1
|
|
Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
|
|
EP3735985A1
|
|
A novel orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications
|
|
WO2019186277A1
|
|
Ultrasensitive hiv-1 p24 detection assay
|
|
EP3715477A1
|
|
Composition of primers for detecting high grade squamous intraepithelial lesion
|
|
WO2019155002A1
|
|
Anti-prevotella bacteriocin methods and compositions
|
|
WO2019138084A1
|
|
Phenanthrolinone derivatives for use in the treatment of bacterial infections
|
|
EP3728553A1
|
|
Hydrogel-based organ-on-chip microfluidic device
|
|
CN111886342A
|
|
Lassa vaccine
|
|
EP3724215A1
|
|
Peptidomimetics, method of synthesis and uses thereof
|
